logo-loader
viewIntegumen

Integumen delighted with results of E.Coli detection pilot

The AIM-listed company’s Rinocloud AI platform was used to test samples from a fully autonomous data buoy.

Integumen -
Integumen believes there is potential for Rawtest’s remote monitoring to be applied widely

Integumen PLC (LON:SKIN) says a project in Ireland to test reservoir water for E.coli returned results with almost 100% accuracy in a matter of seconds.

The Remote Automated Water Test research project (RAWTest) using Artificial Intelligence (AI) ran for three years at the Inniscarra reservoir in Cork.

Integumen was part of a consortium that also comprised the Irish Environmental Protection Agency (EPA), Cork Institute of Technology (CIT) and the CIT Nimbus embedded systems research institute.

The AIM-listed company’s Rinocloud AI platform was used to test samples from a fully autonomous data buoy.

E.coli bacteria in the water was detected with 99.3% accuracy in 3.37 seconds compared to current standard test detection time of between 5-7 days.

Wireless transmission of water data for 13 key AI features indicators was identified from more than 1000 data elements.

Integumen believes there is potential for Rawtest’s remote monitoring to be applied to public buildings to test for listeria; for malaria in third-world countries; milk contamination and in fermentation processes such as brewing.

Quick facts: Integumen

Price: 1.84 GBX

AIM:SKIN
Market: AIM
Market Cap: £19.73 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Integumen named herein, including the promotion by the Company of Integumen in any Content on the Site, the Company receives from said issuer...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Integumen PLC 'the number one thought leader in skin microbiome and AI'

Integumen PLC's (LON:SKIN) Gerry Brandon recaps on 2019 and key highlights including the acquisition of RinoCloud and the deal done with Parity Group. Brandon adds that they're intending to double the size of its Labskin laboratory in York, currently at 3,162 square feet, which could provide...

on 20/12/19

2 min read